Analysis of mechanistic pathway models in drug discovery: P38 pathway

Biotechnology Progress

Volumn 24, Issue 1, 2008, Pages 96-109

  Hendriks, Bart S ^a   Hua, Fei ^a   Chabot, Jeffrey R ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASES; MATHEMATICAL MODELS; PROTEINS; SIGNAL TRANSDUCTION;

CELLULAR VARIABILITY; COMPUTATIONAL MODEL; DRUG DISCOVERY; PATHWAY DYNAMICS;

DRUG PRODUCTS;

LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE P38; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; BIOLOGICAL MODEL; COMPUTER SIMULATION; CONFERENCE PAPER; DRUG EFFECT; HUMAN; INFLAMMATION; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; COMPUTER SIMULATION; HUMANS; INFLAMMATION; LIPOPOLYSACCHARIDES; MODELS, BIOLOGICAL; P38 MITOGEN-ACTIVATED PROTEIN KINASES; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 38949102687     PISSN: 87567938     EISSN: None     Source Type: Journal    
DOI: 10.1021/bp070084g     Document Type: Conference Paper

References (33)

1. Aldridge, B. B.; Burke, J. M.; Lauffenburger, D. A.; Sorger, P. K. Physicochemical modelling of cell signalling pathways. Nat. Cell Biol. 2006, 8 (11), 1195-1203.
2. Fussenegger, M.; Bailey, J. E.; Varner, J. A mathematical model of caspase function in apoptosis. Nat. Biotechnol. 2000, 18 (7), 768-774.
3. Hendriks, B. S.; Cook, J.; Burke, J. M.; Beusmans, J. M.; Lauffenburger, D. A.; de Graaf, D. Computational modelling of ErbB family phosphorylation dynamics in response to transforming growth factor alpha and heregulin indicates spatial compartmentation of phosphatase activity. IEE Proc. Syst. Biol. 2006, 153 (1), 22-33.
4. Hendriks, B. S.; Griffiths, G. J.; Benson, R.; Kenyon, D.; Lazzara, M.; Swinton, J.; Beck, S.; Hickinson, M.; Beusmans, J. M.; Lauffenburger, D.; de Graaf, D. Decreased internalisation of erbB1 mutants in lung cancer is linked with a mechanism conferring sensitivity to gefitinib. IEE Proc. Syst. Biol. 2006, 153 (6), 457-466.
5. Hatakeyama, M.; Kimura, S.; Naka, T.; Kawasaki, T.; Yumoto, N.; Ichikawa, M.; Kim, J. H.; Saito, K.; Saeki, M.; Shirouzu, M.; Yokoyama, S.; Konagaya, A. A computational model on the modulation of mitogen-activated protein kinase (MAPK) and Akt pathways in heregulin-induced ErbB signalling. Biochem. J. 2003, 373 (Pt 2), 451-463.
6. Hoffmann, A.; Levchenko, A.; Scott, M. L.; Baltimore, D. The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation. Science 2002, 298 (5596), 1241-1245.
7. Hua, F.; Cornejo, M. G.; Cardone, M. H.; Stokes, C. L.; Lauffenburger, D. A. Effects of Bcl-2 levels on Fas signaling-induced caspase-3 activation: molecular genetic tests of computational model predictions. J. Immunol. 2005, 175 (2), 985-995.
8. Schoeberl, B.; Eichler-Jonsson, C.; Gilles, E. D.; Muller, G. Computational modeling of the dynamics of the MAP kinase cascade activated by surface and internalized EGF receptors. Nat. Biotechnol. 2002, 20 (4), 370-375.
9. Sedaghat, A. R.; Sherman, A.; Quon, M. J. A mathematical model of metabolic insulin signaling pathways. Am. J. Physiol. 2002, 283 (5), E1084-E1101.
10. Kumar, N.; Hendriks, B. S.; Janes, K. A.; de Graaf, D.; Lauffenburger, D. A. Applying computational modeling to drug discovery and development. Drug Discovery Today 2006, 11 (17-18), 806-811.
11. Scott, D. L.; Kingsley, G. H. Tumor necrosis factor inhibitors for rheumatoid arthritis. New Engl. J. Med. 2006, 355 (7), 704-712.
12. Martin, M. U.; Wesche, H. Summary and comparison of the signaling mechanisms of the Toll/interleukin-1 receptor family. Biochim. Biophys. Acta 2002, 1592 (3), 265-280.
13. Palsson-McDermott, E. M.; O'Neill, L. A. Signal transduction by the lipopolysaccharide receptor, Toll-like receptor-4. Immunology 2004, 113 (2), 153-162.
14. Lye, E.; Mirtsos, C.; Suzuki, N.; Suzuki, S.; Yeh, W. C. The role of interleukin 1 receptor-associated kinase-4 (IRAK-4) kinase activity in IRAK-4-mediated signaling. J. Biol. Chem. 2004, 279 (39), 40653-40658.
15. Akira, S.; Takeda, K. Toll-like receptor signalling. Nat. Rev. Immunol. 2004, 4 (7), 499-511.
16. Engel, K.; Kotlyarov, A.; Gaestel, M. Leptomycin B-sensitive nuclear export of MAPKAP kinase 2 is regulated by phosphorylation. EMBO J. 1998, 17, (12), 3363-3371.
17. Shi, Y.; Gaestel, M. In the cellular garden of forking paths: how p38 MAPKs signal for downstream assistance. Biol. Chem. 2002, 383 (10), 1519-1536.
18. Meng, W.; Swenson, L. L.; Fitzgibbon, M. J.; Hayakawa, K.; Ter, Haar, E.; Behrens, A. E.; Fulghum, J. R.; Lippke, J. A. Structure of mitogen-activated protein kinase-activated protein (MAPKAP) kinase 2 suggests a bifunctional switch that couples kinase activation with nuclear export. J. Biol. Chem. 2002, 277 (40), 37401-37405.
19. Cheung, P. C.; Campbell, D. G.; Nebreda, A. R.; Cohen, P. Feedback control of the protein kinase TAK1 by SAPK2a/p38alpha. EMBO J. 2003, 22 (21), 5793-5805.
20. Ip, S. H.; Johnson, M. L.; Ackers, G. K. Kinetics of deoxyhemoglobin subunit dissociation determined by haptoglobin binding: estimation of the equilibrium constant from forward and reverse rates. Biochemistry 1976, 15 (3), 654-660.
21. Kellett, G. L.; Gutfreund, H. Reactions of haemoglobin dimers after ligand dissociation. Nature 1970, 227 (5261), 921-926.
22. Noble, R. W.; Reichlin, M.; Gibson, Q. H. The reactions of antibodies with hemeprotein antgens. The measurement of reaction kinetics and stoichiometry by fluorescence quenching. J. Biol. Chem. 1969, 244 (9), 2403-2411.
23. Segel, I. H. Enzyme Kinetics; John Wiley & Sons: New York, 1975.
24. Pant, D.; Ghosh, A. Automated oncogene detection in complex protein networks with applications to the MAPK signal transduction pathway. Biophys. Chem. 2005, 113 (3), 275-288.
25. Pant, D. K.; Ghosh, A. A systems biology approach for the study of cumulative oncogenes with applications to the MAPK signal transduction pathway. Biophys. Chem. 2006, 119 (1), 49-60.
26. Loewe, S. The problem of synergism and antagonism of combined drugs. Arzneimittelforschung 1953, 3 (6), 285-290.
27. Janes, K. A.; Albeck, J. G.; Gaudet, S.; Sorger, P. K.; Lauffenburger, D. A.; Yaffe, M. B. A systems model of signaling identifies a molecular basis set for cytokine-induced apoptosis. Science 2005, 310 (5754), 1646-1653.
28. Janes, K. A.; Kelly, J. R.; Gaudet, S.; Albeck, J. G.; Sorger, P. K.; Lauffenburger, D. A. Cue-signal-response analysis of TNF-induced apoptosis by partial least squares regression of dynamic multivariate data. J. Comput. Biol. 2004, 11 (4), 544-561.
29. Janes, K. A.; Yaffe, M. B. Data-driven modelling of signal-transduction networks. Nat. Rev. Mol. Cell Biol. 2006, 7(11), 820-828.
30. Brown, K. S.; Sethna, J. P. Statistical mechanical approaches to models with many poorly known parameters. Phys. Rev. E: Stat., Nonlinear, Soft Matter Phys. 2003, 68 (2 Pt 1), 021904.
31. Brown, K. S.; Hill, C. C.; Calero, G. A.; Myers, C. R.; Lee, K. H.; Sethna, J. P.; Cerione, R. A. The statistical mechanics of complex signaling networks: nerve growth factor signaling. Phys. Biol. 2004, I (3-4), 184-195.
32. Waterfall, J. J.; Casey, F. P.; Gutenkunst, R. N.; Brown, K. S.; Myers, C. R.; Brouwer, P. W.; Elser, V.; Sethna, J. P. Sloppy-model universality class and the Vandermonde matrix. Phys. Rev. Lett. 2006, 97 (15), 150601.
33. Oehler, R.; Zellner, M.; Hefel, B.; Weingartmann, G.; Spittler, A.; Struse, H. M.; Roth, E. Influence of heat shock on cell volume regulation: protection from hypertonic challenge in a human monocyte cell line. FASEB J. 1998, 12 (7), 553-560.